BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2588 related articles for article (PubMed ID: 8038593)

  • 1. Low-dose tumour necrosis factor-alpha (TNF-alpha) and melphalan in hyperthermic isolated limb perfusion. Results from a pilot study performed in the United Kingdom.
    Hill S; Thomas JM
    Melanoma Res; 1994 Mar; 4 Suppl 1():31-4. PubMed ID: 8038593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion.
    Hill S; Fawcett WJ; Sheldon J; Soni N; Williams T; Thomas JM
    Br J Surg; 1993 Aug; 80(8):995-7. PubMed ID: 8402100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.
    Vaglini M; Santinami M; Manzi R; Inglese MG; Santoro N; Persiani L; Belli F
    Melanoma Res; 1994 Mar; 4 Suppl 1():35-8. PubMed ID: 8038594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.
    Hohenberger P; Bida B; Schlag PM
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():14-5. PubMed ID: 8946039
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs].
    Abu-Abid S; Gutman M; Lev D; Inbar M; Chaitchik S; Sorkine P; Rudick V; Meller I; Klausner JM
    Harefuah; 1996 Oct; 131(7-8):227-32, 296, 295. PubMed ID: 8940515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.
    Liénard D; Eggermont AM; Schraffordt Koops H; Kroon BB; Rosenkaimer F; Autier P; Lejeune FJ
    Melanoma Res; 1994 Mar; 4 Suppl 1():21-6. PubMed ID: 8038591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
    Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Rosenkaimer F; Gérain J; Klaase J; Kroon B; Vanderveken J; Schmitz P
    J Infus Chemother; 1995; 5(2):73-81. PubMed ID: 8521239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
    Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
    Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of tumour necrosis factor (TNF) in isolated perfusion: results and side effects. The NCI results.
    Fraker DL; Alexander HR
    Melanoma Res; 1994 Mar; 4 Suppl 1():27-9. PubMed ID: 8038592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha and melphalan on the human fibrinolytic system.
    Zwaveling JH; Maring JK; Mulder AB; Bom VJ; van Ginkel RJ; Schraffordt Koops H; Girbes AR; Hoekstra HJ; van der Meer J
    Cancer Res; 1996 Sep; 56(17):3948-53. PubMed ID: 8752162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    J Clin Oncol; 1996 Feb; 14(2):479-89. PubMed ID: 8636761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.
    Gutman M; Inbar M; Lev-Shlush D; Abu-Abid S; Mozes M; Chaitchik S; Meller I; Klausner JM
    Cancer; 1997 Mar; 79(6):1129-37. PubMed ID: 9070490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of isolation-perfusion of the limbs in melanomas and sarcomas].
    Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Kroon B
    Ann Chir; 1995; 49(1):9-12. PubMed ID: 7741477
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 20. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
    Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
    Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 130.